DE60023860D1 - Verfahren zur herstellung von rekombinanten peptiden - Google Patents

Verfahren zur herstellung von rekombinanten peptiden

Info

Publication number
DE60023860D1
DE60023860D1 DE60023860T DE60023860T DE60023860D1 DE 60023860 D1 DE60023860 D1 DE 60023860D1 DE 60023860 T DE60023860 T DE 60023860T DE 60023860 T DE60023860 T DE 60023860T DE 60023860 D1 DE60023860 D1 DE 60023860D1
Authority
DE
Germany
Prior art keywords
production
recombinant peptides
peptides
recombinant
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60023860T
Other languages
English (en)
Other versions
DE60023860T2 (de
Inventor
D Better
D Gavit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xoma Technology Ltd USA
Original Assignee
Xoma Technology Ltd USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Technology Ltd USA filed Critical Xoma Technology Ltd USA
Application granted granted Critical
Publication of DE60023860D1 publication Critical patent/DE60023860D1/de
Publication of DE60023860T2 publication Critical patent/DE60023860T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4742Bactericidal/Permeability-increasing protein [BPI]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/35Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
DE60023860T 1999-03-18 2000-03-17 Verfahren zur herstellung von rekombinanten peptiden Expired - Lifetime DE60023860T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US271970 1999-03-18
US09/271,970 US6242219B1 (en) 1999-03-18 1999-03-18 Methods for recombinant peptide production
PCT/US2000/007148 WO2000055322A1 (en) 1999-03-18 2000-03-17 Improved methods for recombinant peptide production

Publications (2)

Publication Number Publication Date
DE60023860D1 true DE60023860D1 (de) 2005-12-15
DE60023860T2 DE60023860T2 (de) 2006-08-03

Family

ID=23037863

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60023860T Expired - Lifetime DE60023860T2 (de) 1999-03-18 2000-03-17 Verfahren zur herstellung von rekombinanten peptiden

Country Status (10)

Country Link
US (4) US6242219B1 (de)
EP (1) EP1165782B1 (de)
JP (1) JP2002538824A (de)
AT (1) ATE309353T1 (de)
AU (1) AU782359B2 (de)
CA (1) CA2365697C (de)
DE (1) DE60023860T2 (de)
ES (1) ES2253212T3 (de)
NZ (1) NZ514230A (de)
WO (1) WO2000055322A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754211B2 (en) * 1992-04-10 2010-07-13 Research Development Foundation Immunotoxins directed against c-erbB-2(HER-2/neu) related surface antigens
US6946261B1 (en) * 1998-11-20 2005-09-20 Migenix Inc. Efficient methods for producing anti-microbial cationic peptides in host cells
US6242219B1 (en) * 1999-03-18 2001-06-05 Xoma (Us) Llc Methods for recombinant peptide production
US20030219854A1 (en) * 2002-03-21 2003-11-27 Micrologix Biotech Inc. Methods for producing modified anti-infective peptides
ATE443767T1 (de) * 2002-04-22 2009-10-15 Dow Global Technologies Inc Kostengünstige herstellung von peptiden
JP4643445B2 (ja) * 2002-11-12 2011-03-02 ベクトン,ディッキンソン アンド カンパニー バイオマーカープロフィールを使用した敗血症またはsirsの診断
US7736633B2 (en) * 2005-09-28 2010-06-15 E.I. Du Pont De Nemours And Company Method for enhancing effects of colorants and conditioners
US20100234568A1 (en) * 2006-10-19 2010-09-16 Linda Jane Decarolis Identification of peptide tags for the production of insoluble peptides by sequence scanning
US7662913B2 (en) 2006-10-19 2010-02-16 E. I. Du Pont De Nemours And Company Cystatin-based peptide tags for the expression and purification of bioactive peptides
US7732569B2 (en) 2006-10-19 2010-06-08 E.I. Du Pont De Nemours And Company Zein-based peptide tags for the expression and purification of bioactive peptides
US7829311B2 (en) 2007-07-25 2010-11-09 E.I. Du Pont De Nemours And Company Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
US7951559B2 (en) * 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
US7678883B2 (en) * 2007-07-25 2010-03-16 E.I. Du Pont De Nemours And Company Solubility tags for the expression and purification of bioactive peptides
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
US9115182B2 (en) 2011-06-21 2015-08-25 E I Du Pont De Nemours And Company Cysteine cross-linked structural peptides
US9062312B2 (en) 2011-06-21 2015-06-23 Danisco Us Inc. Fusion peptides comprising multi-functional peptidic solubility tags for efficient production, processing and surface applications
EP2792686A1 (de) 2013-04-17 2014-10-22 Heinrich-Heine-Universität Düsseldorf Verfahren zur Expression von Peptiden und Proteinen
WO2016089782A1 (en) 2014-12-01 2016-06-09 Pfenex Inc. Fusion partners for peptide production
US10538596B2 (en) 2015-01-09 2020-01-21 Adalta Limited CXCR4 binding molecules and methods of use thereof
WO2023108026A2 (en) 2021-12-08 2023-06-15 Oakgrove Bio Llc Biological production of histidine-rich peptides

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2933704A1 (de) 1979-08-21 1981-03-26 Festo Kg, 73734 Esslingen Druckmittelverbindung zwischen einem ventilblock und einem zumindest einen doppelt wirkenden druckmittelmotor aufweisenden verbraucher
US5206154A (en) 1985-01-28 1993-04-27 Xoma Corporation Method of producing cecropins by microbiological techniques
AU6104786A (en) * 1985-08-12 1987-02-19 Syntex (U.S.A.) Inc. Fusion proteins using trple gene
US5416007A (en) * 1987-03-20 1995-05-16 Creative Biomolecules, Inc. Enhanced proteolytic cleavage of recombinant fusion proteins
US4958007A (en) * 1988-05-17 1990-09-18 Schering-Plough Corp. Extraction of human interleukin-4- from bacteria
IT1226551B (it) * 1988-07-29 1991-01-24 Sclavo Spa Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita' verso l'alfa- fetoproteina e loro impiego in campo diagnostico
US5376546A (en) 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
US5837491A (en) 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences
US5621083A (en) 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US5593866A (en) 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
US5789377A (en) 1992-08-21 1998-08-04 University Of British Columbia Treatment of endotoxin-associated disorders with cationic peptides
CA2142306A1 (en) 1992-08-21 1994-03-03 Robert E.W. Hancock Cationic peptides and method for production
US5420019A (en) 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
AU3909893A (en) 1993-03-04 1994-09-26 Dmitry Nikolaevich Motovilov Secondary electrical power source based on motovilov transformers
US5733872A (en) 1993-03-12 1998-03-31 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5652332A (en) 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
AU694108B2 (en) 1993-03-12 1998-07-16 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
MX9401807A (es) 1993-03-12 1995-01-31 Xoma Corp Usos terapeuticos de productos de proteina que incrementan lapermeabilidad/bactericidas.
US5348942A (en) 1993-03-12 1994-09-20 Xoma Corporation Therapeutic uses of bactericidal/permeability increasing protein products
JPH10508576A (ja) 1994-09-15 1998-08-25 ゾーマ コーポレイション 抗真菌性ペプチド
JP2001520631A (ja) 1995-07-20 2001-10-30 ゾーマ コーポレイション 抗真菌性ペプチド
US5851802A (en) 1996-03-22 1998-12-22 Xoma Corporation Methods for recombinant microbial production of fusion proteins and BPI-derived peptides
US6242219B1 (en) * 1999-03-18 2001-06-05 Xoma (Us) Llc Methods for recombinant peptide production

Also Published As

Publication number Publication date
US20090246831A1 (en) 2009-10-01
DE60023860T2 (de) 2006-08-03
EP1165782B1 (de) 2005-11-09
US7749731B2 (en) 2010-07-06
JP2002538824A (ja) 2002-11-19
CA2365697A1 (en) 2000-09-21
US6242219B1 (en) 2001-06-05
US7247454B2 (en) 2007-07-24
EP1165782A1 (de) 2002-01-02
CA2365697C (en) 2007-01-09
AU782359B2 (en) 2005-07-21
US6500648B1 (en) 2002-12-31
NZ514230A (en) 2004-01-30
US20030194782A1 (en) 2003-10-16
ES2253212T3 (es) 2006-06-01
AU3758700A (en) 2000-10-04
US20020009781A1 (en) 2002-01-24
WO2000055322A1 (en) 2000-09-21
ATE309353T1 (de) 2005-11-15

Similar Documents

Publication Publication Date Title
DE60023860D1 (de) Verfahren zur herstellung von rekombinanten peptiden
ATE218579T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin- analogen
DE69739996D1 (de) Methoden und Zusammensetzungen zur Herstellung von Polypeptiden
DE60023936D1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE69827083D1 (de) Vakuumverfahren zur Herstellung von Siloxan-Oxyalkylen-Copolymeren
DE69731834D1 (de) Agouti verwandtes gen
DE69611658D1 (de) Verfahren zur Herstellung von Ethylenglykol
ATE354668T1 (de) Verfahren zur herstellung von tripeptiden
DE69713022D1 (de) Verfahren zur Herstellung von Unterkleidung
BR9707819A (pt) Imunogenos peptidicos
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
DE69725580D1 (de) Prozess zur herstellung von aza zyclohexapeptide
MX9806041A (es) Proteina purificada sr-p70.
ATE397081T1 (de) Erhöhte expression von proteinen mittels gfp
DE60309847D1 (de) Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga
ATE204023T1 (de) Enzymatische verfahren zur herstellung von (s)- cyanhydrinen
DK0942992T3 (da) O-fucosyltransferase
MY138219A (en) Biologically active peptides
DE19983485T1 (de) Verfahren zur Herstellung von Gasfedern
DK0977859T3 (da) Den neurotrofiske faktor NNT-1
DE60016183D1 (de) Verfahren zur verwendung von viraler replicase
DE60010147D1 (de) Verfahren zur Herstellung von organischen Aziden
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition